, International Agency for Research on Cancers, GLOBOCAN 2012: country fast stat, 2012.
, Endometrial carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up, Ann Oncol, vol.20, issue.4, pp.29-31, 2009.
,
, Pathology of endometrioid carcinoma, Bull Cancer, vol.99, pp.7-12, 2012.
,
, ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up, Int J Gynecol Cancer, vol.26, pp.2-30, 2016.
,
, Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study, Int J Gynecol Cancer, vol.19, pp.873-881, 2009.
,
, Contribution of lymphoscintigraphy for sentinel lymph node biopsy in women with early stage endometrial cancer: results of the SENTI-ENDO study, Ann Surg Oncol, vol.22, pp.1980-1986, 2015.
,
, The French National Cancer Institute. Cancers gynécologiques: recommandations et outils d'aide à la pratique, 2017.
, Radiotherapy of cervix and endometrial carcinoma, Cancer Radiother, vol.20, pp.189-95, 2016.
, Adjuvant treatment for endometrial cancer: literature review and recommendations by the Comité de l'évolution des pratiques en oncologie (CEPO), Gynecol Oncol, vol.131, pp.231-271, 2013.
,
, The role of postoperative radiation therapy for endometrial cancer: Executive summary of an American Society for Radiation Oncology evidence-based guideline, Pract Radiat Oncol, vol.4, pp.137-181, 2014.
,
, Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO consensus conference risk groups: results from the FRANCOGYN study group, Gynecol Oncol, vol.144, pp.107-119, 2017.
,
, Joint recommendations of the French society of gynecologic oncology (SFOG) and of the French college of obstetricians and gynecologists (CNGOF), Gynecol Obstet Fertil Senol, vol.45, pp.715-740, 2017.
,
, Lymphvascular space involvement: an independent prognostic factor in endometrial cancer, Gynecol Oncol, vol.96, pp.799-804, 2005.
,
, Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer?, Gynecol Oncol, vol.87, pp.243-249, 2002.
,
, Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I-II endometrioid-type endometrial cancer, Anticancer Res, vol.29, pp.1715-1735, 2009.
, Lymphvascular space involvement compromises the survival of patients with stage I endometrial cancer: results of a multicenter study, Eur J Surg Oncol, vol.33, pp.644-651, 2007.
,
, Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer, Gynecol Oncol, vol.124, pp.31-36, 2012.
,
, Substantial lymphvascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--a pooled analysis of PORTEC 1 and 2 trials, Eur J Cancer, vol.51, pp.1742-50, 2015.
,
, Lymphovascular space invasion in uterine corpus cancer: what is its prognostic significance in the absence of lymph node metastases?, Gynecol Oncol, vol.142, pp.278-82, 2016.
,
, Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer, Eur J Obstet Gynecol Reprod Biol, vol.186, pp.63-70, 2015.
,
, Predicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study group, Br J Cancer, vol.115, pp.1296-303, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01417859
,
, The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation, Gynecol Oncol, vol.103, pp.87-93, 2006.
, Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma, Lancet, vol.355, pp.1404-1415, 2000.
,
, Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis, J Natl Cancer Inst, vol.104, pp.1625-1659, 2012.
,
, A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study, Gynecol Oncol, vol.92, pp.744-51, 2004.
,
, Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial, Lancet, vol.375, pp.816-839, 2010.
,
, External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma: a prospective, randomized study--quality-of-life analysis, Int J Gynecol Cancer, vol.22, pp.1281-1289, 2012.
,
, Long-term impact of endometrial cancer diagnosis and treatment on health-related quality of life and cancer survivorship: results from the randomized PORTEC-2 trial, Int J Radiat Oncol Biol Phys, vol.93, pp.797-809, 2015.
,
, Assessing the quality of life in patients with endometrial cancer treated with adjuvant radiotherapy, Int J Gynecol Cancer, vol.25, pp.1526-1559, 2015.
,
, Quality of life and sexual functioning in endometrial cancer survivors, Gynecol Oncol, vol.121, pp.169-73, 2011.
,
, Sexual function after intracavitary vaginal brachytherapy for early-stage endometrial carcinoma, Int J Gynecol Cancer, vol.22, pp.703-711, 2012.
,
, Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers, Gynecol Oncol, vol.136, pp.521-529, 2015.